Doseology Sciences Inc. (DOSEF)
USD 0.14
(0.0%)
USD 0.14
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2022 | 41.28 Thousand CAD | 127.82% |
| 2021 | -148.37 Thousand CAD | 0.0% |
| 2020 | - CAD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 Q2 | -7201.00 CAD | -124.99% |
| 2023 Q1 | 28.81 Thousand CAD | -24.85% |
| 2022 FY | 41.28 Thousand CAD | 127.82% |
| 2022 Q3 | 2450.00 CAD | -57.8% |
| 2022 Q2 | 5805.00 CAD | 209.26% |
| 2022 Q1 | -5313.00 CAD | 96.44% |
| 2022 Q4 | 38.34 Thousand CAD | 1465.06% |
| 2021 Q3 | 755.00 CAD | 0.0% |
| 2021 Q1 | - CAD | 0.0% |
| 2021 Q2 | - CAD | 0.0% |
| 2021 Q4 | -149.13 Thousand CAD | -19852.85% |
| 2021 FY | -148.37 Thousand CAD | 0.0% |
| 2020 Q4 | - CAD | 0.0% |
| 2020 Q3 | - CAD | 0.0% |
| 2020 Q2 | - CAD | 0.0% |
| 2020 Q1 | - CAD | 0.0% |
| 2020 FY | - CAD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 14.99 Million USD | 99.725% |
| Nanobac Pharmaceuticals, Incorporated | 3102.00 USD | -1230.948% |
| SQZ Biotechnologies Company | 9.79 Million USD | 99.578% |
| Evofem Biosciences, Inc. | 11.7 Million USD | 99.647% |
| Santhera Pharmaceuticals Holding AG | 119.1 Million USD | 99.965% |
| Mesoblast Limited | -35.16 Million USD | 100.117% |
| Propanc Biopharma, Inc. | -34.15 Thousand USD | 220.896% |
| Genus plc | 178.7 Million USD | 99.977% |
| VioQuest Pharmaceuticals, Inc. | - USD | -Infinity% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | 89.934% |
| Marizyme, Inc. | 457.7 Thousand USD | 90.98% |
| ContraFect Corporation | -154 Thousand USD | 126.809% |
| Nymox Pharmaceutical Corporation | -11 Thousand USD | 475.327% |
| PsyBio Therapeutics Corp. | -50 Thousand USD | 182.572% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | 46.215% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | 37.187% |
| AXIM Biotechnologies, Inc. | -387.5 Thousand USD | 110.654% |
| MultiCell Technologies, Inc. | 49.32 USD | -83610.462% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 40.26 Million USD | 99.897% |
| EV Biologics, Inc. | 48.9 Thousand USD | 15.571% |
| Q BioMed Inc. | -8988.00 USD | 559.346% |
| Emmaus Life Sciences, Inc. | 28.25 Million USD | 99.854% |
| Neon Bloom, Inc. | - USD | -Infinity% |
| Mosaic ImmunoEngineering Inc. | - USD | -Infinity% |
| Biomind Labs Inc. | -15.42 Thousand USD | 367.674% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 220.1 Million USD | 99.981% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | 41.02% |
| Skye Bioscience, Inc. | -124.25 Thousand USD | 133.228% |
| Therapeutic Solutions International, Inc. | 62.22 Thousand USD | 33.652% |
| THC Farmaceuticals, Inc. | -4952.00 USD | 933.724% |
| Arch Therapeutics, Inc. | -2439.00 USD | 1792.743% |
| IMV Inc. | -962.29 Thousand USD | 104.29% |
| Acro Biomedical Co., Ltd. | 140.5 Thousand USD | 70.615% |
| Curative Biotechnology, Inc. | -97.51 Thousand USD | 142.338% |
| GB Sciences, Inc. | -624.00 USD | 6716.346% |
| Alpha Cognition Inc. | -86.02 Thousand USD | 147.991% |
| HST Global, Inc. | - USD | -Infinity% |
| CSL Limited | 7.56 Billion USD | 99.999% |
| Halberd Corporation | -208.00 USD | 19949.038% |
| Enzolytics Inc. | 30.7 Thousand USD | -34.447% |
| Resverlogix Corp. | - USD | -Infinity% |
| Affymax, Inc. | 1.35 Million USD | 96.958% |
| SYBLEU INC | 11.69 Thousand USD | -252.992% |
| Nuo Therapeutics, Inc. | 482.43 Thousand USD | 91.442% |
| argenx SE | 1.1 Billion USD | 99.996% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | -25.79 Million USD | 100.16% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | - USD | -Infinity% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | 93.313% |
| Zenith Capital Corp. | - USD | -Infinity% |
| Genscript Biotech Corporation | 409.55 Million USD | 99.99% |
| Ember Therapeutics, Inc. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | -8856.00 USD | 566.192% |
| WPD Pharmaceuticals Inc. | - USD | -Infinity% |
| American Oriental Bioengineering, Inc. | 44.35 Million USD | 99.907% |
| Provectus Biopharmaceuticals, Inc. | -1.14 Million USD | 103.617% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | 987.98 Thousand USD | 95.821% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 9.61 Million USD | 99.57% |
| Cotinga Pharmaceuticals Inc. | -83.84 Thousand USD | 149.239% |
| BioStem Technologies, Inc. | 15.42 Million USD | 99.732% |
| ONE Bio Corp. | 20.12 Million USD | 99.795% |
| Reve Technologies, Inc. | - USD | -Infinity% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | - USD | -Infinity% |
| Agentix Corp. | - USD | -Infinity% |
| LadRx Corporation | -11.83 Thousand USD | 448.847% |
| Cell Source, Inc. | - USD | -Infinity% |
| ProtoKinetix, Incorporated | -48.25 Thousand USD | 185.551% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | 76.616% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | 76.616% |
| NovAccess Global Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | -514.51 Thousand USD | 108.024% |
| Itoco Inc. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | - USD | -Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | -Infinity% |
| Kadimastem Ltd | -630.13 Thousand USD | 106.552% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | - USD | -Infinity% |
| CytoDyn Inc. | -29 Thousand USD | 242.366% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Qrons Inc. | - USD | -Infinity% |
| Alseres Pharmaceuticals, Inc. | 450.04 Thousand USD | 90.826% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | -319.5 Thousand USD | 112.922% |
| Rebus Holdings, Inc. | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | -Infinity% |
| International Stem Cell Corporation | 4.6 Million USD | 99.104% |
| Bioxytran, Inc. | -8285.00 USD | 598.322% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | - USD | -Infinity% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | - USD | -Infinity% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | -373 Thousand USD | 111.069% |
| Neutra Corp. | 14.33 Thousand USD | -188.008% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 150.349% |
| PureTech Health plc | -1.6 Million USD | 102.576% |
| Coeptis Therapeutics, Inc. | -1 Million USD | 104.124% |
| IXICO plc | 3.27 Million USD | 98.737% |
| IntelGenx Technologies Corp. | -694 Thousand USD | 105.949% |
| Gelesis Holdings, Inc. | -1.79 Million USD | 102.305% |
| CSL Limited | 7.7 Billion USD | 99.999% |
| Cellectis S.A. | 18 Thousand USD | -129.367% |